Most LQT2 Mutations Reduce Kv11.1 (hERG) Current by a Class 2 (Trafficking-Deficient) Mechanism
Top Cited Papers
- 24 January 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 113 (3) , 365-373
- https://doi.org/10.1161/circulationaha.105.570200
Abstract
Background— The KCNH2 or human ether-a-go-go related gene ( hERG ) encodes the Kv11.1 α-subunit of the rapidly activating delayed rectifier K + current ( I Kr ) in the heart. Type 2 congenital long-QT syndrome (LQT2) results from KCNH2 mutations that cause loss of Kv11.1 channel function. Several mechanisms have been identified, including disruption of Kv11.1 channel synthesis (class 1), protein trafficking (class 2), gating (class 3), or permeation (class 4). For a few class 2 LQT2-Kv11.1 channels, it is possible to increase surface membrane expression of Kv11.1 current ( I Kv11.1 ). We tested the hypotheses that (1) most LQT2 missense mutations generate trafficking-deficient Kv11.1 channels, and (2) their trafficking-deficient phenotype can be corrected. Methods and Results— Wild-type (WT)-Kv11.1 channels and 34 missense LQT2-Kv11.1 channels were expressed in HEK293 cells. With Western blot analyses, 28 LQT2-Kv11.1 channels had a trafficking-deficient (class 2) phenotype. For the majority of these mutations, the class 2 phenotype could be corrected when cells were incubated for 24 hours at reduced temperature (27°C) or in the drugs E4031 or thapsigargin. Four of the 6 LQT2-Kv11.1 channels that had a wild-type–like trafficking phenotype did not cause loss of Kv11.1 function, which suggests that these channels are uncommon sequence variants. Conclusions— This is the first study to identify a dominant mechanism, class 2, for the loss of Kv11.1 channel function in LQT2 and to report that the class 2 phenotype for many of these mutant channels can be corrected. This suggests that if therapeutic strategies to correct protein trafficking abnormalities can be developed, it may offer clinical benefits for LQT2 patients.Keywords
This publication has 41 references indexed in Scilit:
- Intragenic Suppression of Trafficking-Defective KCNH2 Channels Associated with Long QT SyndromeMolecular Pharmacology, 2005
- Cystic FibrosisNew England Journal of Medicine, 2005
- Patency of the preterm fetal ductus arteriosus is regulated by endothelial nitric oxide synthase and is independent of vasa vasorum in the mouseAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004
- Evidence against the Rescue of Defective ΔF508-CFTR Cellular Processing by Curcumin in Cell Culture and Mouse ModelsJournal of Biological Chemistry, 2004
- Correction of the CF defect by curcumin: hypes and disappointmentsBioEssays, 2004
- Ethnic Differences in Cardiac Potassium Channel Variants: Implications for Genetic Susceptibility to Sudden Cardiac Death and Genetic Testing for Congenital Long QT SyndromeMayo Clinic Proceedings, 2003
- Thapsigargin Selectively Rescues the Trafficking Defective LQT2 Channels G601S and F805CJournal of Biological Chemistry, 2003
- Structural and Functional Role of the Extracellular S5-P Linker in the HERG Potassium ChannelThe Journal of general physiology, 2002
- Analysis of the Cyclic Nucleotide Binding Domain of the HERG Potassium Channel and Interactions with KCNE2Journal of Biological Chemistry, 2001
- Crystal Structure and Functional Analysis of the HERG Potassium Channel N Terminus: A Eukaryotic PAS DomainPublished by Elsevier ,1998